SAB Biotherapeutics
No bio yet
This person is not in the org chart
This person is not in any offices
SAB Biotherapeutics
SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.